{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-045844","form_type":"8-K","ticker":"TBPH","cik":"0001583107","company_name":"Theravance Biopharma, Inc.","filed_at":"2023-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.512856+00:00","generated_at":"2026-06-17T01:22:35.327245+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"low","headline":"Theravance Biopharma presents at Needham Healthcare Conference; no material news disclosed","bullets":["Management team presented at 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023.","Slide deck furnished as Exhibit 99.1 contains only a title slide; no financial or pipeline updates provided.","Filing under Item 7.01 is for Regulation FD purposes and is not deemed filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-045844","json":"https://secwatch.observer/filing/0001104659-23-045844.json","markdown":"https://secwatch.observer/filing/0001104659-23-045844.md","text":"https://secwatch.observer/filing/0001104659-23-045844.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465923045844/0001104659-23-045844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465923045844/tm2312970d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:22:35.327245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}